Empowering partners with the best transgenic mouse for fully human antibody discovery

Biocytogen & RenMab commercial benefits

Licensing Options

License directly with Biocytogen
Option to use through other CROs or in-house

Co-development Opportunities

Exclusive partnership opportunities using our RenMiceTM HiTS Platform


Flexible terms tailored to accommodate different antibody programs

Additional Benefits

  • Rapid innovation based on RenMab platform

    Robust and long-term mutual collaboration

  • Access to Biocytogen’s Service Portfolio

    Biocytogen covers all preclinical research up to IND

  • Access to the China Market

    Biocytogen is positioned to help our partners enter China’s emerging healthcare market

  • Flexible Financial/Operational Terms & Partnership

    Biocytogen tailors fair and mutually beneficial terms to both parties